Cargando…
Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke
Background: RNA-binding motif protein 3 (RBM3) is a cold-induced marker of good functional outcome of ischemic stroke that is promising as a protective target. Fibroblast growth factor 21 (FGF21) is an obesity- and temperature-related hormone that upregulates the expression of RBM3, which is benefic...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875775/ https://www.ncbi.nlm.nih.gov/pubmed/35207221 http://dx.doi.org/10.3390/jcm11040949 |
_version_ | 1784658013334798336 |
---|---|
author | Ávila-Gómez, Paulo Pérez-Mato, María Hervella, Pablo Dopico-López, Antonio da Silva-Candal, Andrés Bugallo-Casal, Ana López-Amoedo, Sonia Candamo-Lourido, María Sobrino, Tomás Iglesias-Rey, Ramón Castillo, José Campos, Francisco |
author_facet | Ávila-Gómez, Paulo Pérez-Mato, María Hervella, Pablo Dopico-López, Antonio da Silva-Candal, Andrés Bugallo-Casal, Ana López-Amoedo, Sonia Candamo-Lourido, María Sobrino, Tomás Iglesias-Rey, Ramón Castillo, José Campos, Francisco |
author_sort | Ávila-Gómez, Paulo |
collection | PubMed |
description | Background: RNA-binding motif protein 3 (RBM3) is a cold-induced marker of good functional outcome of ischemic stroke that is promising as a protective target. Fibroblast growth factor 21 (FGF21) is an obesity- and temperature-related hormone that upregulates the expression of RBM3, which is beneficial as a recombinant treatment and has been tested under different experimental pathological conditions, including stroke. However, the interaction between RBM3 and FGF21 has not yet been tested for clinical stroke conditions. Methods: In a sample of 66 stroke patients, we analyzed the associations between the FGF21 and RBM3 serum concentrations on admission and at 72 h, body weight, maximum temperature during the first 24 h, and the outcome of patients at 3 months. We also analyzed their association with biomarkers of obesity (adiponectin and leptin) and inflammation (interleukin-6 (IL-6) and interleukin (IL-10)). Results: Higher concentrations of FGF21 on admission and RBM3 at 72 h were associated with good outcomes. Serum FGF21 and RBM3 were directly related to body mass index and inversely related to the maximum temperature during the first 24 h. We found a positive association between the FGF21 concentrations in obese patients with leptin and a negative correlation with adiponectin in non-obese participants. Conclusions: This clinical study demonstrates the association between RBM3 and FGF21 levels and the outcome of stroke patients. Although further investigations are required, these data support the pharmacological induction of RBM3 as a promising protective therapy. |
format | Online Article Text |
id | pubmed-8875775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88757752022-02-26 Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke Ávila-Gómez, Paulo Pérez-Mato, María Hervella, Pablo Dopico-López, Antonio da Silva-Candal, Andrés Bugallo-Casal, Ana López-Amoedo, Sonia Candamo-Lourido, María Sobrino, Tomás Iglesias-Rey, Ramón Castillo, José Campos, Francisco J Clin Med Article Background: RNA-binding motif protein 3 (RBM3) is a cold-induced marker of good functional outcome of ischemic stroke that is promising as a protective target. Fibroblast growth factor 21 (FGF21) is an obesity- and temperature-related hormone that upregulates the expression of RBM3, which is beneficial as a recombinant treatment and has been tested under different experimental pathological conditions, including stroke. However, the interaction between RBM3 and FGF21 has not yet been tested for clinical stroke conditions. Methods: In a sample of 66 stroke patients, we analyzed the associations between the FGF21 and RBM3 serum concentrations on admission and at 72 h, body weight, maximum temperature during the first 24 h, and the outcome of patients at 3 months. We also analyzed their association with biomarkers of obesity (adiponectin and leptin) and inflammation (interleukin-6 (IL-6) and interleukin (IL-10)). Results: Higher concentrations of FGF21 on admission and RBM3 at 72 h were associated with good outcomes. Serum FGF21 and RBM3 were directly related to body mass index and inversely related to the maximum temperature during the first 24 h. We found a positive association between the FGF21 concentrations in obese patients with leptin and a negative correlation with adiponectin in non-obese participants. Conclusions: This clinical study demonstrates the association between RBM3 and FGF21 levels and the outcome of stroke patients. Although further investigations are required, these data support the pharmacological induction of RBM3 as a promising protective therapy. MDPI 2022-02-11 /pmc/articles/PMC8875775/ /pubmed/35207221 http://dx.doi.org/10.3390/jcm11040949 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ávila-Gómez, Paulo Pérez-Mato, María Hervella, Pablo Dopico-López, Antonio da Silva-Candal, Andrés Bugallo-Casal, Ana López-Amoedo, Sonia Candamo-Lourido, María Sobrino, Tomás Iglesias-Rey, Ramón Castillo, José Campos, Francisco Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke |
title | Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke |
title_full | Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke |
title_fullStr | Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke |
title_full_unstemmed | Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke |
title_short | Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke |
title_sort | associations between rna-binding motif protein 3, fibroblast growth factor 21, and clinical outcome in patients with stroke |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875775/ https://www.ncbi.nlm.nih.gov/pubmed/35207221 http://dx.doi.org/10.3390/jcm11040949 |
work_keys_str_mv | AT avilagomezpaulo associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT perezmatomaria associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT hervellapablo associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT dopicolopezantonio associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT dasilvacandalandres associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT bugallocasalana associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT lopezamoedosonia associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT candamolouridomaria associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT sobrinotomas associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT iglesiasreyramon associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT castillojose associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke AT camposfrancisco associationsbetweenrnabindingmotifprotein3fibroblastgrowthfactor21andclinicaloutcomeinpatientswithstroke |